| Literature DB >> 16763152 |
Norman L Letvin1, John R Mascola, Yue Sun, Darci A Gorgone, Adam P Buzby, Ling Xu, Zhi-Yong Yang, Bimal Chakrabarti, Srinivas S Rao, Jörn E Schmitz, David C Montefiori, Brianne R Barker, Fred L Bookstein, Gary J Nabel.
Abstract
Vaccine-induced cellular immunity controls virus replication in simian immunodeficiency virus (SIV)-infected monkeys only transiently, leading to the question of whether such vaccines for AIDS will be effective. We immunized monkeys with plasmid DNA and replication-defective adenoviral vectors encoding SIV proteins and then challenged them with pathogenic SIV. Although these monkeys demonstrated a reduction in viremia restricted to the early phase of SIV infection, they showed a prolonged survival. This survival was associated with preserved central memory CD4+ T lymphocytes and could be predicted by the magnitude of the vaccine-induced cellular immune response. These immune correlates of vaccine efficacy should guide the evaluation of AIDS vaccines in humans.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16763152 PMCID: PMC2365913 DOI: 10.1126/science.1124226
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728